160 related articles for article (PubMed ID: 9516840)
1. Human Krüppel-related 3 (HKR3): a candidate for the 1p36 neuroblastoma tumour suppressor gene?
Maris JM; Jensen J; Sulman EP; Beltinger CP; Allen C; Biegel JA; Brodeur GM; White PS
Eur J Cancer; 1997 Oct; 33(12):1991-6. PubMed ID: 9516840
[TBL] [Abstract][Full Text] [Related]
2. Cloning, chromosomal localization, physical mapping, and genomic characterization of HKR3.
Maris JM; Jensen SJ; Sulman EP; Beltinger CP; Gates K; Allen C; Biegel JA; Brodeur GM; White PS
Genomics; 1996 Jul; 35(2):289-98. PubMed ID: 8661141
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of the region of distal 1p commonly deleted in neuroblastoma.
White PS; Maris JM; Sulman EP; Jensen SJ; Kyemba SM; Beltinger CP; Allen C; Kramer DL; Biegel JA; Brodeur GM
Eur J Cancer; 1997 Oct; 33(12):1957-61. PubMed ID: 9516832
[TBL] [Abstract][Full Text] [Related]
4. Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig.
Bauer A; Savelyeva L; Claas A; Praml C; Berthold F; Schwab M
Genes Chromosomes Cancer; 2001 Jul; 31(3):228-39. PubMed ID: 11391793
[TBL] [Abstract][Full Text] [Related]
5. Detailed molecular analysis of 1p36 in neuroblastoma.
White PS; Thompson PM; Seifried BA; Sulman EP; Jensen SJ; Guo C; Maris JM; Hogarty MD; Allen C; Biegel JA; Matise TC; Gregory SG; Reynolds CP; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):37-41. PubMed ID: 11464901
[TBL] [Abstract][Full Text] [Related]
6. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
Thompson PM; Maris JM; Hogarty MD; Seeger RC; Reynolds CP; Brodeur GM; White PS
Cancer Res; 2001 Jan; 61(2):679-86. PubMed ID: 11212268
[TBL] [Abstract][Full Text] [Related]
7. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
8. Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours.
Martinsson T; Sjöberg RM; Hallstensson K; Nordling M; Hedborg F; Kogner P
Eur J Cancer; 1997 Oct; 33(12):1997-2001. PubMed ID: 9516841
[TBL] [Abstract][Full Text] [Related]
9. Definition and characterization of a region of 1p36.3 consistently deleted in neuroblastoma.
White PS; Thompson PM; Gotoh T; Okawa ER; Igarashi J; Kok M; Winter C; Gregory SG; Hogarty MD; Maris JM; Brodeur GM
Oncogene; 2005 Apr; 24(16):2684-94. PubMed ID: 15829979
[TBL] [Abstract][Full Text] [Related]
10. Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas.
Hogarty MD; Liu X; Guo C; Thompson PM; Weiss MJ; White PS; Sulman EP; Brodeur GM; Maris JM
Med Pediatr Oncol; 2000 Dec; 35(6):512-5. PubMed ID: 11107105
[TBL] [Abstract][Full Text] [Related]
11. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3.
White PS; Maris JM; Beltinger C; Sulman E; Marshall HN; Fujimori M; Kaufman BA; Biegel JA; Allen C; Hilliard C; Valentine MB; Look AT; Enomoto H; Sakiyama S; Brodeur GM
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5520-4. PubMed ID: 7777541
[TBL] [Abstract][Full Text] [Related]
12. Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1.
Spieker N; Beitsma M; Van Sluis P; Chan A; Caron H; Versteeg R
Genes Chromosomes Cancer; 2001 Jun; 31(2):172-81. PubMed ID: 11319804
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line.
Ohira M; Kageyama H; Mihara M; Furuta S; Machida T; Shishikura T; Takayasu H; Islam A; Nakamura Y; Takahashi M; Tomioka N; Sakiyama S; Kaneko Y; Toyoda A; Hattori M; Sakaki Y; Ohki M; Horii A; Soeda E; Inazawa J; Seki N; Kuma H; Nozawa I; Nakagawara A
Oncogene; 2000 Aug; 19(37):4302-7. PubMed ID: 10980605
[TBL] [Abstract][Full Text] [Related]
14. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.
Ejeskär K; Sjöberg RM; Abel F; Kogner P; Ambros PF; Martinsson T
Med Pediatr Oncol; 2001 Jan; 36(1):61-6. PubMed ID: 11464908
[TBL] [Abstract][Full Text] [Related]
15. No evidence for the presence of an imprinted neuroblastoma suppressor gene within chromosome sub-band 1p36.3.
Hogarty MD; Winter CL; Liu X; Guo C; White PS; Look AT; Brodeur GM; Maris JM
Cancer Res; 2002 Nov; 62(22):6481-4. PubMed ID: 12438240
[TBL] [Abstract][Full Text] [Related]
16. Expression and sequence analysis of candidates for the 1p36.31 tumor suppressor gene deleted in neuroblastomas.
Okawa ER; Gotoh T; Manne J; Igarashi J; Fujita T; Silverman KA; Xhao H; Mosse YP; White PS; Brodeur GM
Oncogene; 2008 Jan; 27(6):803-10. PubMed ID: 17667943
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of chromosome 1p deletions in neuroblastoma.
Maris JM; Guo C; Blake D; White PS; Hogarty MD; Thompson PM; Rajalingam V; Gerbing R; Stram DO; Matthay KK; Seeger RC; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):32-6. PubMed ID: 11464900
[TBL] [Abstract][Full Text] [Related]
18. Constitutional 1p36 deletion in a child with neuroblastoma.
Biegel JA; White PS; Marshall HN; Fujimori M; Zackai EH; Scher CD; Brodeur GM; Emanuel BS
Am J Hum Genet; 1993 Jan; 52(1):176-82. PubMed ID: 8434586
[TBL] [Abstract][Full Text] [Related]
19. Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted.
Caron H; Spieker N; Godfried M; Veenstra M; van Sluis P; de Kraker J; Voûte P; Versteeg R
Genes Chromosomes Cancer; 2001 Feb; 30(2):168-74. PubMed ID: 11135433
[TBL] [Abstract][Full Text] [Related]
20. Identification of the homozygously deleted region at chromosome 1p36.2 in human neuroblastoma.
Nakagawara A; Ohira M; Kageyama H; Mihara M; Furuta S; Machida T; Takayasu H; Islam A; Nakamura Y; Takahashi M; Shishikura T; Kaneko Y; Toyoda A; Hattori M; Sakaki Y; Ohki M; Horii A; Soeda E; Inazawa J; Seki N; Kuma H; Nozawa I; Sakiyama S
Med Pediatr Oncol; 2000 Dec; 35(6):516-21. PubMed ID: 11107106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
